The Latest in Schizophrenia & Other Psychotic Disorders

Pimavanserin for psychosis in patients with Parkinson’s disease

September 1, 2016

Adjusting the dosing of antipsychotics and other psychotropics in renal disease

July 28, 2016

When to adjust the dosing of psychotropics in patients with renal impairment

July 28, 2016

Rediscovering clozapine: Adverse effects develop—what should you do now?

July 28, 2016

Schizophrenia & Other Psychotic Disorders

Rediscovering clozapine

June 29, 2016

Schizophrenia & Other Psychotic Disorders

Using lipid guidelines to manage metabolic syndrome for patients taking an antipsychotic

June 28, 2016

Rediscovering clozapine: After a turbulent history, current guidance on initiating and monitoring

June 28, 2016

Schizophrenia & Other Psychotic Disorders

Long-acting injectable aripiprazole lauroxil for schizophrenia

June 28, 2016

Schizophrenia & Other Psychotic Disorders

Scopolamine-induced mania: ‘Theoretically possible, but statistically improbable'

June 28, 2016

Benzodiazepines might succeed as monotherapy for cannabinoid-induced catatonia

May 26, 2016

The doctor is sick

April 25, 2016

Schizophrenia & Other Psychotic Disorders

Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia?

April 25, 2016

Schizophrenia & Other Psychotic Disorders

Don’t assume that psychiatric patients lack capacity to make decisions about care

April 11, 2016

Schizophrenia & Other Psychotic Disorders

The ‘worried well’ and the ‘walking wounded’: How will we know them?; ‘Struggling with inner demons’

March 28, 2016

Antipsychotic polypharmacy back to monotherapy

March 28, 2016

Schizophrenia & Other Psychotic Disorders